Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum.
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001797:Blood Protein Electrophoresis; D001835:Body Weight; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D003967:Diarrhea; D005260:Female; D006086:Graft vs Host Disease / Q000097:blood / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D006087:Graft vs Host Reaction; D006454:Hemoglobins; D007165:Immunosuppression Therapy; D007958:Leukocyte Count; D008099:Liver / Q000473:pathology / Q000528:radiation effects; D051379:Mice; D008810:Mice, Inbred C57BL / Q000276:immunology; D008808:Mice, Inbred CBA / Q000276:immunology; D011817:Rabbits / Q000276:immunology; D011830:Radiation Effects; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D006454:Hemoglobins